20,000 Dicks Sporting Goods Inc (NYSE:DKS) shares with value of $974,642 were sold by CHIRICO EMANUEL. The acquisition was announced in a document with the SEC which is available through this hyperlink. $12,200 worth of stock was bought by Rubin Steven D on Wednesday, May 31.
The most recent non open market insider trade was completed by FROST PHILLIP MD ET AL on 07/24/2017, and was a disposition of 45,000 shares with a final price of $6.41. The shares were purchased at an average price of $6.08 per share, for a total transaction of $152,000.00. The CEO & Chairman, 10% Owner added these shares by way of transaction on August 16, 2017. (OPK) formed a down wedge with $5.67 target or 8.00 % below today's $6.16 share price.
Analyst mean recommendation on a stock by the analyst community is at 1.80. The shares were purchased at an average price of $6.19 per share, for a total transaction of $61,900.00.
On Tuesday, August 1st, Phillip Md Et Al Frost bought 46,600 shares of Opko Health stock. The stock has "Sell" rating by UBS on Wednesday, August 17. The disclosure for this bought can be found here. during the last ninety days, executives purchased 1,638,200 stocks of company shares worth at $10,370,607. The firm has a 50 day moving average of $6.36 and a 200 day moving average of $7.24. The company has market cap of $28.34 million.
Opko Health, Inc. (OPK) shares are down -0.32% for the week and that has got investors and traders sitting up and taking note. For the same quarter from the prior fiscal year, firm posted $0.02 EPS. on consensus, financial stock experts estimate that Opko Health to post ($0.20) earnings per share for the financial year.
Analyst Stock Ratings: Williams-Sonoma, Inc. (WSM), Bed Bath & Beyond Inc. (BBBY)
In the a year ago there have been a total of 28 insider trades, including 0 open market buys and 28 sells. The company also recently announced a quarterly dividend, which will be paid on Friday, August 25th.
Opko Health, Inc. (OPK) is expected to post revenue of $319.32 Million in the current quarter, according to consensus of 5 analysts.
For this year, Opko Health, Inc. Opko Health, Inc.'s average EBITDA per Share Growth Rate was -124.6 percent during the past 12 months. To make a proper assessment, investors seek a sound estimate of this year's and next year's earnings per share (EPS), as well as a strong sense of how much the company will earn even farther down the road.
CEO & Chairman, 10% Owner, Frost Phillip Md Et Al, purchased 25,000 common shares of Opko Health, Inc. (CREE) stake by 5.54% reported in 2016Q4 SEC filing. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of USA & global trademark and copyright law. The company achieved year to date performance of -34.19% and disseminated yield of -30.53% for the past six months. Research firm Zacks lifted stocks of Opko Health from a "hold" recommendation to a "buy" recommendation and fixed a $7.25 price target for The corporation in a study report published on Fri, Jul 21st. Ladenburg Thalmann Financial Services reiterated a "buy" rating and set a $19.50 price objective on shares of Opko Health in a report on Friday, June 16th. BidaskClub upgraded Opko Health from a "strong sell" rating to a "sell" rating in a report on Thursday, June 22nd. Opko Health had 14 analyst reports since August 11, 2015 according to SRatingsIntel. One analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the stock. In the previous year there have been a total of 180 insider trades, including 169 open market buys and 11 sells. Dorsey & Whitney Trust Company Llc sold 4,370 shares as Cvs Caremark Corporation (CVS)'s stock declined 4.23%. BlackRock Inc. raised its position in Opko Health by 11,481.3% in the first quarter. Paloma Partners Management Co now owns 160,970 shares of the biotechnology company's stock valued at $1,288,000 after buying an additional 66,327 shares during the period. State Street Corp increased its position in shares of Opko Health by 40.3% in the first quarter. Verition Fund Mgmt Ltd Liability has 0.04% invested in Opko Health Inc.
Opko Health, Inc. (OPK) now has a Return on Assets (ROA) value of -2.8 Percent. Under Special Management now owns 5,061,154 shares of the biotechnology company's stock worth $40,489,000 after buying an additional 1,944,549 shares in the last quarter. Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD boosted its position in Opko Health by 14.8% in the second quarter. Vanguard Group Inc. now owns 26,322,001 shares of the biotechnology company's stock worth $210,576,000 after buying an additional 1,112,843 shares in the last quarter. However, the company's most recent quarter decrease of -41.7% looks unattractive. Gabelli Funds Ltd Com holds 0.02% of its portfolio in Opko Health Inc. Its segments include Pharmaceutical, Diagnostics and Corporate.